Cardiol Therapeutics Inc.
CRDL
$1.15
$0.00990.87%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 18.56M | 18.67M | 19.18M | 18.00M | 14.17M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 28.93M | 29.03M | 29.40M | 28.16M | 23.50M |
Operating Income | -28.93M | -29.03M | -29.40M | -28.16M | -23.50M |
Income Before Tax | -26.99M | -25.77M | -26.80M | -26.57M | -21.66M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -26.99 | -25.77 | -26.80 | -26.57 | -21.66 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -26.99M | -25.77M | -26.80M | -26.57M | -21.66M |
EBIT | -28.93M | -29.03M | -29.40M | -28.16M | -23.50M |
EBITDA | -28.86M | -28.93M | -29.25M | -28.03M | -23.35M |
EPS Basic | -0.35 | -0.35 | -0.38 | -0.39 | -0.33 |
Normalized Basic EPS | -0.22 | -0.22 | -0.24 | -0.24 | -0.20 |
EPS Diluted | -0.35 | -0.35 | -0.38 | -0.39 | -0.33 |
Normalized Diluted EPS | -0.22 | -0.22 | -0.24 | -0.24 | -0.20 |
Average Basic Shares Outstanding | 315.51M | 301.61M | 286.26M | 271.01M | 265.66M |
Average Diluted Shares Outstanding | 315.51M | 301.61M | 286.26M | 271.01M | 265.66M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |